Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer-Reference-Cited by-同舟云学术

Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer

Published:2024-07-17 Issue: Volume: Page:
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Broderick Amanda,Pan Elizabeth,Li Jinju,Chu Alec,Hwang Clara^ORCID,Barata Pedro C.,Cackowski Frank Cameron^ORCID,Labriola Matthew^ORCID,Ghose Alyssa,Bilen Mehmet Asim,Kilari Deepak,Thapa Bicky,Piero Michael,Graham Laura^ORCID,Tripathi Abhishek,Garje Rohan,Koshkin Vadim S.,Hernandez Erik,Dorff Tanya B.^ORCID,Schweizer Michael Thomas^ORCID,Alva Ajjai Shivaram,McKay Rana R.^ORCID,Armstrong Andrew J.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41391-024-00869-1.pdf

Reference36 articles.

1. Siegel R, Miller K, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

2. Mohler JL, Antonarakis ES, Armstrong AJ, D’Amico AV, Davis BJ, Dorff T, et al. Prostate Cancer, Version 2.2019, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw. 2019;17:479–505.

3. Dehm SM, Tindall DJ. Androgen receptor structural and functional elements: role and regulation in prostate cancer. Mol Endocrinol. 2007;21:2855–63.

4. Mohler JL, Gregory CW, Ford OH, Kim D, Weaver CM, Petrusz P, et al. The androgen axis in recurrent prostate cancer. Clin Cancer Res. 2004;10:440–8.

5. Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, et al. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med. 2000;6:703–6.